Notably, mutations in FGFR1 and FGFR3 are commonly observed in cases of CCA [41], while a previous study observed FGFR4 overexpression in around 50% of all CCA cases, strongly indicating its carcinogenesis role [42]. Here, FGFR4 is linked to cholangiocarcinoma.